Age-related macular degeneration (AMD), classified into dry and wet types, poses a significant threat to the vision of the ...

The Phase I/IIa CLARICO trial of OpCT-001 marks the first clinical trial of an investigational induced pluripotent stem ...

BAYRY begins human trials for OpCT-001, an experimental cell therapy for treating primary photoreceptor diseases.

New research shows that retinal neurons can rewire to preserve vision in retinitis pigmentosa, a genetic disease causing blindness.

Scientists at the Jules Stein Eye Institute at the David Geffen School of Medicine at UCLA have discovered that certain ...

UCLA scientists found that in early retinitis pigmentosa, rod bipolar cells in mice rewire to connect with cones, preserving ...

Most people who are allergic to cats aren’t reacting to the fur—they’re reacting to a protein in cat saliva called Fel d 1.

From quirky shapes to wacky abilities, the animal kingdom never ceases to amaze us! It is full of bizarre eyes that defy ...

Human vision relies on photoreceptor cells in the retina that react to visible light and trigger neurons in the optic nerve to send signals to the brain. Degradation of these photoreceptors is the ...

SHANGHAI, May 10, 2025 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven clinical-stage gene therapy company focused on developing unique and novel solutions for rare and severe diseases, ...